Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder. This story matters for Health & Wellness readers tracking obesity. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. ObesityNews curates and briefs the health & wellness stories that matter. Our editorial policy →